Investors Sell Express Scripts (ESRX) on Strength (ESRX)

Investors sold shares of Express Scripts Holding Co (NASDAQ:ESRX) on strength during trading hours on Thursday. $28.35 million flowed into the stock on the tick-up and $66.57 million flowed out of the stock on the tick-down, for a money net flow of $38.22 million out of the stock. Of all equities tracked, Express Scripts had the 8th highest net out-flow for the day. Express Scripts traded up $0.38 for the day and closed at $96.15

ESRX has been the topic of a number of research analyst reports. BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Tuesday, September 18th. ValuEngine upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a research report on Monday, September 17th. Zacks Investment Research upgraded shares of Express Scripts from a “strong sell” rating to a “hold” rating in a research report on Tuesday, June 26th. Credit Suisse Group downgraded shares of Express Scripts from an “outperform” rating to a “neutral” rating and boosted their target price for the company from $90.00 to $96.50 in a research report on Tuesday, September 18th. Finally, Robert W. Baird downgraded shares of Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 target price for the company. in a research report on Friday, July 20th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $86.36.

The stock has a market capitalization of $53.41 billion, a price-to-earnings ratio of 13.54, a PEG ratio of 1.20 and a beta of 1.01. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.59 and a current ratio of 0.71.

Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings data on Wednesday, August 1st. The company reported $2.22 earnings per share for the quarter, topping analysts’ consensus estimates of $2.20 by $0.02. The business had revenue of $25.64 billion during the quarter, compared to the consensus estimate of $25.43 billion. Express Scripts had a net margin of 4.65% and a return on equity of 25.49%. The company’s revenue was up 1.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.73 earnings per share. Research analysts expect that Express Scripts Holding Co will post 9.07 earnings per share for the current fiscal year.

In other Express Scripts news, insider Christine Houston sold 12,898 shares of the company’s stock in a transaction dated Friday, August 10th. The shares were sold at an average price of $85.00, for a total value of $1,096,330.00. Following the completion of the transaction, the insider now owns 110,908 shares in the company, valued at $9,427,180. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.79% of the company’s stock.

Several institutional investors have recently modified their holdings of ESRX. Abrams Capital Management L.P. acquired a new position in shares of Express Scripts in the second quarter worth about $204,846,000. Canada Pension Plan Investment Board raised its position in shares of Express Scripts by 124.5% in the second quarter. Canada Pension Plan Investment Board now owns 1,971,200 shares of the company’s stock worth $152,196,000 after acquiring an additional 1,093,200 shares during the period. FMR LLC raised its position in shares of Express Scripts by 117.6% in the second quarter. FMR LLC now owns 1,419,840 shares of the company’s stock worth $109,626,000 after acquiring an additional 767,426 shares during the period. Bank of Montreal Can acquired a new position in shares of Express Scripts in the second quarter worth about $54,695,000. Finally, BlackRock Inc. raised its position in shares of Express Scripts by 1.5% in the second quarter. BlackRock Inc. now owns 35,424,185 shares of the company’s stock worth $2,735,103,000 after acquiring an additional 538,578 shares during the period. Institutional investors and hedge funds own 84.73% of the company’s stock.

Express Scripts Company Profile (NASDAQ:ESRX)

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Featured Story: Google Finance Portfolio Workaround

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply